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Abstract
Norovirus (NoV) RNA was detected in the stools of 6 out 14 (42.8%) 8–12-week-old cats with enteritis from a feline shelter, in
New York State. Upon sequence analysis of the complete capsid, the six NoVs were found to be identical, suggesting the
spread of a unique NoV strain in the shelter. The full-length genomic sequence (7839 nt) of one feline NoV, CU081210E/
2010/US, was determined. In the capsid protein VP1 region, the virus displayed the highest amino acid identity to animal
genogroup IV genotype 2 (GIV.2) NoVs: lion/Pistoia-387/06/IT (97.9%) and dog/Bari-170/07/IT (90.4%). These findings
document the discovery of a novel feline calicivirus, different from vesiviruses, and extend the spectrum of NoV host range.
Epidemiological studies using feline NoV-specific diagnostic tools and experimental infection of cats are required to
understand whether NoVs have a pathogenic role in this species.
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Introduction
Noroviruses (NoVs) are non-enveloped, polyadenylated, single-
stranded, positive-sense RNA viruses and represent a distinct
genus in the family Caliciviridae [1]. Human NoVs have a
worldwide distribution and represent the major cause of non
bacterial gastroenteritis. The genome of NoV possesses three open
reading frames (ORFs) encoding for a large non-structural
polyprotein, a major capsid protein (VP1) and a small basic
structural protein (VP2). Based on the full-length VP1, NoVs have
been classified into five distinct genogroups (GI to V) [2]. GI, GII
and GIV NoVs infect humans, with GII NoVs accounting for the
majority of human infections [3]. NoVs have also been detected in
animals and classified as GII (swine), GIII (ruminants), GIV (lions
and dogs) and GV (mice) [1,4].
Several studies have documented that NoVs also circulate in
carnivores. NoVs were first identified in the feces of a captive lion
cub with severe hemorrhagic enteritis in Italy [5]. Subsequently
NoVs genetically related to the lion NoV were identified in the
fecal samples of dogs with diarrhea in Italy and Greece [4,6].
Based on the full-length VP1, the lion and dog NoVs were
classified as a distinct genotype (GIV.2) within GIV, along with
human Alphatron-like NoVs (GIV.1) [2]. Some canine NoVs are
not classifiable within any established genogroups (GI-V), as they
are distantly related to all other human and animal NoVs in the
VP1 region [7–9].
Various viral agents including coronavirus, parvovirus, astro-
virus, adenovirus, rotavirus and vesiviruses (feline calicivirus,
FCV) have been identified in the stools of cats, although there is
limited information on their role as enteric pathogens [10–13].
Small round structured viruses (SRSVs) have been detected
occasionally in the feces of cats by using electron microscopy
(EM) and have been mostly characterized as FCV [12,14].
Interestingly, Norwalk-like 27-nm virus particles, clearly distin-
guishable from FCVs, were detected from an outbreak of
vomiting and diarrhea in adult cats in Germany in 1987,
although the viruses were neither adapted to cultivation in vitro
nor characterized further [15]. More recently, antibodies specific
for the baculovirus-expressed VP1 of Lion/NoV/Pistoia-387/
06/IT were detected in the sera of cats by ELISA. These previous
findings suggest that NoVs infect cats [16].
In this study, the stools of cats with diarrhea were screened for
norovirus by reverse transcription (RT)-PCR with several
calicivirus universal primer sets followed by sequence confirma-
tion. Also, the full-length sequence of a feline NoV was determined
for the first time.
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Collection of samples
A total of 24 fecal samples were collected in 2010 from domestic
cats (Felis catus) by the veterinary clinics of The Ohio State
University (OSU) (10 samples, collection A) and Cornell University
(CU) (14 samples, collection B). Diarrheic specimens were collected
from hospitalized cats with gastroenteric symptoms. The 14 CU
fecal samples, collected in July and August 2010, originated from
young cats (8–12 weeks old) housed in a New York State animal
shelter. The OSU cat specimens were collected in three different
periods (July, November and December 2010) from animals of
different ages (4 months to 8 years old) (Table 1). During the period
of hospitalization, cats were located in single cages and feces were
collected directly from the cat litter and identified individually with
an alpha-numeric code. Fecal samples were stored at 220uC until
processing. The fecal samples, collected during this study, were
negative for common feline parasites.
RNA extraction
A 10% fecal suspension in 0.01 M phosphate buffered saline
(PBS, pH 7.2) was made and the debris were removed by
centrifugation at 160006 g for 3 min. The stool suspension was
treated with DNase (RNase-Free DNase Set, Qiagen, Inc.,
Valencia, CA) and extracted using the RNeasy Mini Kit (Qiagen,
Inc., Valencia, CA) and stored at 270uC.
RT-PCR screening for calicivirus
The samples were analyzed by using broadly reactive primers
p289–p290 targeting the highly conserved motifs (DYSKWDST
and YGDD) of the RNA-dependent RNA polymerase (RdRp)
[17]. Primer pair p289–p290 amplifies a fragment of 319 bp for
NoVs and of 331 bp for vesiviruses and sapoviruses. Amplicons of
the expected size (319 bp) were obtained from three samples
(CU081210E, CU081210J and CU081210M). The amplicons
were purified after gel excision with the QIAquick PCR
Purification Kit (Qiagen, Inc., Valencia, CA) and sequenced
directly from both directions. Upon sequence analysis of the
275 nt fragment, the three samples displayed 94% nt identity to
the lion NoV/GIV.2/Pistoia-387/06/IT, confirming the diagno-
sis of NoV infection.
Full-length genome sequencing of the feline NoV strain
CU081210E
The primers are listed in Table 2. The 39 end of the genome
(,3500 bp) was amplified with a 39-RACE protocol [18] using
specific forward primers (FNoV-F1 and FNoV-F2) designed
based on the sequence of the p290/289 amplicons and reverse
primers QO and QI. The internal fragment (,2000 bp) was
amplified using specific reverse primers (FNoV-R1 and FNoV-
R2) and the forward primer P1210, targeting the NTPase
region [19]. The 59end fragment was obtained using specific
reverse primers (FNoV-R5 and FNoV-R6) and the primer
Table 1. Feline sample collection and results for caliciviruses detection.
SAMPLE








OSU (COLLECTION A) 020911H H December 2010 4 M FECES - -
020911I I December 2010 1Y FECES - -
020911K K December 2010 2Y FECES - -
020911P P December 2010 1Y FECES - -
121310A A November 2010 2Y FECES - -
121310F F November 2010 8Y FECES - -
121310G G November 2010 3Y FECES - -
071510D D July 2010 8Y FECES - -
071510F F July 2010 3Y 3 M FECES - -
071510I I July 2010 1Y 4 M FECES - -
CU (COLLECTION B) 081210A A July 2010 8W FECES - NoV
081210C C July 2010 8W FECES - -
081210D D July 2010 12W FECES FCV -
081210E E July 2010 8W FECES NoV NoV
081210F F July 2010 8W FECES FCV -
081210G G July 2010 8W FECES FCV -
081210H H July 2010 8W FECES FCV -
081210I I July 2010 8W FECES - -
081210J J July 2010 8W FECES NoV NoV
081210K K August 2010 8W FECES - NoV
081210L L August 2010 8W FECES - -
081210M M August 2010 8W FECES NoV NoV
081210N N August 2010 8W FECES - -
081210O O August 2010 8W FECES FCV NoV
1Y: year; M: month; W: week.
doi:10.1371/journal.pone.0032739.t001
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with the 59-RACE System for Rapid Amplification of cDNA
Ends, Version 2.0 (Invitrogen, Corp., Carlsbad, CA) using a 59-
RACE protocol with minor modifications [21] and specific
reverse primers (FNoV-R10 and FNoV-R11). The cDNA was
synthesized using SuperScript III First-Strand cDNA Synthesis
Kit (Invitrogen, Corp., Carlsbad, CA) and PCR was performed
using TaKaRa Ex Taq
TM polymerase (TaKaRaMirus Bio,
Madison, WI).
Cloning and sequencing
The RT-PCR or PCR products were purified using the gel
purification kit (Qiagen, Inc., Valencia, CA) and cloned into pCR-
XL-TOPO vector (Invitrogen, Corp., Carlsbad, CA) for sequenc-
ing. DNA sequencing was performed using BigDye Terminator
Cycle chemistry and an automated sequencer ABI Prism 3100XL
(Applied Biosystems, Foster, CA).
Sequence analysis
Sequence editing, assembling and alignment were performed
using BioEdit Sequence Analysis Editor (version 7.0.9.0) [22].
Basic Local Alignment Search Tool (BLAST, http://www.ncbi.
nlm.nih.gov) was used to find homologous hits in the sequence
databases. Phylogenetic analysis (Neighbor-Joining) with bootstrap
(1,000 replicates) was conducted using MEGA version 5.03 [23].
Identity matrices were calculated without removing the gaps and
with no distance correction.
Pair-wise identity in the full-length VP1 of strain CU081210E to
180 NoV strains was determined using multiple alignments
generated with Bioedit software package vers. 2.1 [22]. The
values were calculated by the uncorrected distance method using a
181-sequence alignment without removing the gaps, following the
outlines of Zheng et al. [2].
Pair-wise identity in the partial polyprotein (,250 aa) was also
calculated using a selection of 72 reference NoV strains for whom
Table 2. Oligonucleotides used for cDNA synthesis and amplification in this study.
Oligonucleotide Polarity Position
a Sequence (59 to 39)
b Note
c Reference
FNoV-F1 + 4480–4503 GGTTATTAAGGCCGCGCTTGACAT A This study
FNoV-R1 2 4659–4681 GGCTGAGAGGGTGTAAATCCAGT A This study
FNoV-F2 + 4507–4530 GGTTAAATTCTCTGCCGAACCCGA A This study
FNoV-R2 2 4626–4648 GTTGACTTGAGAGGTGCAGGGAA A This study
P1210 + 1610–1632 GGICMICCIGGIWKIGGIAARAC A [19]
FNoV-F3 + 5143–5163 CGTGCCCAAGTTCGAAGCCAT S This study
FNoV-R3 2 7251–7274 CATTCCAGTCAACTAGCGTGGTCA S This study
FNoV-F4 + 3434–3455 GTCAAACGTGCCAGTGGTGAAC S This study
FNoV-R4 2 2826–2846 CACTGAGTCCTTTACTGGAGA S This study
FNoV-R5 2 2797–2815 CTTTCGCCCACGACCCTTC A This study
FNoV-R6 2 2787–2805 CGACCCTTCTTGCTCTTAC A This study
FNoV-R7 2 4197–4216 CTTAAGGGCTGCGGTGAATC S This study
FNoV-R8 2 6525–6546 GCAGATTATACTCCTGGTACTG S This study
FNoV-F5 + 5995–6014 ATGAGGCCCAGGTTGTGCAC S This study
FragAF + 1–21 atattaattaaGTGAATGAAGATGGCGTCTAA A [20]
FNoV-F6 + 680–699 GCACTCTACAAACTCAATGG S This study
FNoV-R9 2 532–554 CGAGGTAGATGGCGTAGTGGTAG S This study
FNoV-R10 2 498–518 ACATCTCGAGGATGGAGCCAG A This study
FNoV-R11 2 424–446 GTTTGACTTCACGCTCAGACAGG A This study
FNoV-R12 2 2099–2115 GTGTTGCCAGCCTTGTC S This study
FNoV-F9d + 4655–4677 GCCCACTGGATWTACACCCTCTC A This study
FNoV-R14d 2 7067–7088 CYT GGT TRT ACC CAA ACT CCA C A This study
FNoV-R15 2 4970–4993 CTG ATG GTT GGG TCC TCT GGT CCA A This study
P290d + 4445–4467 GATTACTCCASSTGGGAYTCMAC A [17]
P289d 2 4742–4763 TGACGATTTCATCATCMCCRTA A [17]
QT +/2 39/59end CCAGTGAGCAGAGTGACGAGGACT
CGAGCTCAAGCTTTTTTTTTTTTTTTTT
A [18]
Qo +/2 39/59end CCAGTGAGCAGAGTGACG A [18]
QI 2 39end GAGGACTCGAGCTCAAGC A [18]
AAP + 59end GGCCACGCGTCGACTAGTACGGGI
IGGGIIGGGIIG
A [21]
AUAP + 59end GGCCACGCGTCGACTAGTAC A [21]
aNucleotide position refers to the complete genome sequence of the feline NoV CU081210E (GenBank accession no. JF781268).
bNon viral sequences are indicated in lowercase.
cA: amplification; S:sequencing.
doi:10.1371/journal.pone.0032739.t002
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ORF1 sequences are available. In addition, the full-length
polyprotein was aligned to cognate sequences of five reference
NoV strains and the cleavage sites were predicted on the basis of
conserved aa motives [24,25].
The full length genome sequence of the feline GIV NoV
CU081210E/US was deposited in GenBank with accession
number JF781268.
RT-PCR for the diagnosis of feline NoVs
An RT-PCR specific for feline NoV was developed based on the
cat and lion NoV sequences. Primers FNoV-F9 and FNoV-R15
(Table 2) were designed to amplify a 338-bp amplicon at the 39end
RdRp region. The assay was performed using the QIAGEN one-
step RT-PCR kit (Qiagen, Inc., Valencia, CA). The amplification
program included 50uC for 30 min, 95uC for 15 min, 35 cycles at
94uC for 30 sec, 57uC for 30 sec and 72uC for 60 sec and a final
extension of 10 min at 72uC.
RT-PCR amplification of the ORF2 of feline NoVs
Primers FNoV-F9 and FNoV-R14 were designed to amplify a
2433 bp fragment encompassing the 39 end of ORF1, the full-
length ORF2 and the 59 end of ORF3. The amplification was
performed using the QIAGEN one-step RT-PCR kit (Qiagen,
Inc., Valencia, CA). The thermal conditions consisted in 50uC for
30 min, 95uC for 15 min, 35 cycles at 94uC for 30 sec, 53uC for
30 sec and 72uC for 2 min and 30 sec and a final extension of
10 min at 72uC. The primers are listed in Table 2.
Results
Full-length genome sequencing of the feline NoV strain
CU081210E
In RT-PCR with primers p289/p290, 8 out of the 24 feline
samples (all originated from CU collection B), were positive, but
only 3 samples (CU081210E, CU081210J and CU081210M)
showed a band of the expected size for NoV (319 bp), while the
other 5 samples showed a band of 331 bp and were confirmed as
FCV by sequence analysis (Table 1). Upon sequence analysis, the
feline NoV strains were highly similar to the lion GIV NoV
Pistoia-387/06/IT (94% nt and 98% aa identity) in the 275 nt
fragment. By the 39 RACE protocol, a ,3.5 kb fragment (from the
39end of ORF1 through the poly-A tail) was obtained only for
strain CU081210E. The 7839-bp complete genome sequence of
the cat NoV was determined by a primer walking strategy. By
comparison with a selection of full-length genomic sequences of
GI, GII, GIII and GV NoV strains available in the databases, the
highest nt identity was found to GII NoVs (56.4–57.6% nt).
Nucleotide identity to GI, GIII and GV NoV was $47.1%, while
identity to other caliciviruses (sapovirus, vesivirus, lagovirus,
nebovirus, recovirus and valovirus) ranged from 29.3 to 34.5%
(Table 3, Figure 1).
Three ORFs were identified in the genome of strain
CU081210E, as described for other NoVs [1]. The ORF1 was
5241 nt long and encodes the non-structural polyprotein with a












1237 located between the N-terminal
protein, NTPase, ‘‘3A-like’’ protein, VPg, protease and RdRp,
respectively [24,25].
As most diagnostic primers target highly conserved motives in
the RdRp (ORF1), partial sequences of the 39 end of the RdRp are
available in the databases. A selection of 72 partial sequences of
the RdRp (,250 aa) of NoVs was retrieved from GenBank and
used to compare in detail the feline NoV strain. Identity was
98.9% aa and 94.5% nt to the strain lion/Pistoia-387/06/IT and
98.4% aa and 85.7% nt to strain dog/Bari-170/07/IT. Identity to
human GIV NoVs was 76–78% aa and 69.2–70.3% nt (Table 3).
The ORF2 was 1737 nt long and the predicted size of VP1 was
579 aa. The identity was calculated on a selection of 181 NoV
capsid sequences. The feline NoV displayed 97.9% aa and 94.1%
nt identity to the strain lion/Pistoia-387/06/IT, 90.4% aa and
82% nt to the NoV dog/Bari-170/07/IT and 64.6–68.5% to
human GIV (Alphatron-like) NoVs. Identity to non-GIV NoVs
was 36.7–54.5% aa (Table 3, Figure 2). In the VP1, four regions
were identified, namely the NH2-terminal arm (residues 10–45),
the S-domain (residues 46–221), the P1-subdomain (residues 222–
274 and 451–569) and the P2-domain (residues 275–450) [26]. In
the highly variable P2-domain, identity to the lion and to the dog
strains (Bari-170/07/IT) was 97.1% and 86.3% aa, respectively,
while identity to human GIV NoVs was much lower (,44% aa). A
20-aa insertion was present in the P2-domain of animal GIV
NoVs, with respect to human GIV NoVs.
The ORF3 and the predicted minor structural protein (VP2)
were 765 nt and 255 aa long. In the ORF3, identity was high to
the lion NoV (96.8% aa and 93.9% nt) and the canine strain Bari-
Table 3. Noroviruses identity (%) to the new feline strain fe/CU081210E/10/USA.







ORF1* 60,8–64,4 62,2–69,5 59,8–64,2 69,2–70,3 94,5 85,7 55,7 79,0–86,3 Nucleotide
sequence
62,5–65,1 67,3–75,3 62,5–65,1 76,0–78,0 98,9 98,4 51,2 95,3–98,4 Amino acid
sequence
ORF2 43,3–46,2 50,2–53,9 41,4–43,9 64,6–65,2 94,1 82 46,2 52,8–59,7 Nucleotide
sequence
37,6–41,5 45,5–49,8 36,7–37,4 68,2–68,5 97,9 90,4 36,9 50,2–54,5 Amino acid
sequence
ORF3 26,6–28,2 39,0–47,8 31,9–32,9 58,4–59,3 93,9 72,9 25,2 46,3–47,2 Nucleotide
sequence
25,4–30,3 34,7–44,3 20,9–26,1 58,8–60,7 96,8 77,6 20,2 41,5–44,7 Amino acid
sequence
*The ORF1 identity (%) was calculated on the partial RdRp nucleotide (,750 nt) and amino acid (,250 aa) sequence of 72 representative strains available in GenBank.
doi:10.1371/journal.pone.0032739.t003
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other NoVs strains (Table 3).
A 17-nt overlap was present between the end of ORF1 and the
beginning of ORF2, while there was a 1-nt overlap between ORF2
and ORF3. The 59 untranslated region (UTR) was 10 nt-long,
while the 39 UTR was104 nt long.
RT-PCR for the detection of feline NoVs
Using the sequences of the feline NoVs obtained in the study, a
new diagnostic RT-PCR was developed. By re-screening the
sample collections A and B with primers FNoV-F9 and FNoV-
R15, 3 additional samples tested positive to NoV from the
collection B, but none from collection A. Accordingly, 6 out of the
14 feline diarrheic samples (42.8%) from Cornell University
veterinary clinic were positive for NoV. These samples were
obtained from 8–12 weeks old kittens with enteric signs housed in
a New York shelter (Table 1).
The sequences of a 2.4 kb-genomic fragment of three additional
feline NoV strains (CU081210J, CU081210M, CU081210O) were
obtained and compared with the sequence of strain CU081210E.
The four feline NoV strains displayed 100% nt identity to each
other, suggesting a clonal origin.
Discussion
Feline vesiviruses, commonly referred to as FCV, are wide-
spread in cats and they are associated with mild to severe disease of
the upper respiratory tract [27]. FCV may be detected from
conjunctival, nasal and oropharyngeal swabs and from internal
organs [12,28]. Although it is not clear whether FCV also plays a
role as an enteric pathogen or if it is shed in the feces after primary
localization in other regions, it has been occasionally identified in
the feces of cats and associated with enteric disease [28–31]. Also,
differences in resistance to bile acids have been found between
Figure 1. Neighbor-Joining phylogenetic tree of caliciviruses based on the complete genomes (nucleotide). The newly identified feline
NoV CU081210E/10/USA is in bold. Bootstrap values are shown near branches.
doi:10.1371/journal.pone.0032739.g001
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enteric FCVs have the ability to replicate actively in the enteric
tract while respiratory FCVs do not [14]. By EM observation,
SRSVs have been detected in 6% of the stools of both
symptomatic and asymptomatic cats [12]. In the present study
FCVs were identified by RT-PCR in 5 out of 14 (35.7%) diarrheic
fecal samples of group B while they were not detected from
animals of group A (Table 1).
Also, in this study, a novel calicivirus was discovered in cats and
characterized as a member of the Norovirus genus by sequence
analysis of the complete genome. This novel feline calicivirus was
detected in 6/14 samples collected from cats housed in a shelter in
New York State (collection B) (Table 1). These findings are in
agreement with previous evidence that cats can be infected with
NoVs [15,16]. It is of relevance that animals from group B showed
enteric symptoms and were young kittens almost of the same age
(8 to 12 weeks old). This age period is critical for kittens, since
maternally derived antibodies tend to wane and the animals
become fully susceptible to various pathogens [32]. On the other
hand, NoVs were not detected in animals from group A. This
might reflect either geographic or temporal variations, age-related
patterns of susceptibility or merely the relatively small number of
samples included in the analysis.
The complete sequence of one strain (CU081210E) and partial
(,2.4 kb) sequences of three additional strains (CU081210J,
CU081210M, CU081210O) were analyzed. All the NoV strains
displayed 100% nt identity to each other. The clonal origin of
these viruses suggests that a single NoV strain was spreading
quickly in group B animals, consistent with the highly infectious
nature of NoVs [33].
In the VP1, the feline NoV displayed high aa identity to the
GIV.2 NoV strain lion/Pistoia-387/06/IT (97.9%) and to the dog
strain Bari-170/07/IT (90.4%) while the aa identity was ,68% to
human GIV.1 (Alphatron-like) NoVs (Table 3). Based on the
Figure 2. Neighbor-Joining phylogenetic tree of noroviruses based on the complete capsid sequence (amino acid). The newly
identified feline NoV CU081210E/10/US is in bold. Bootstrap values are shown near branches.
doi:10.1371/journal.pone.0032739.g002
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classified as a GIV.2 genotype (Figure 2). In the hypervariable P2-
domain, the feline NoV strain was highly conserved with respect to
the NoV strains lion/Pistoia-387/06/IT and dog/Bari-170/07/
IT (97.1% and 86.3% aa, respectively) while it was less related to
human GIV NoVs (,44% aa). The P2-domain represents the
protruding region of the capsid protein and is the binding site for
cells and protective antibodies [34,35].
A fragment of the RdRp (the 39end of the ORF1) was used for
analysis and comparison with a large selection of NoV strains
belonging to all genogroups. This part of the NoV genome can be
sequenced easily using the 39-RACE protocol and forward primers
designed in conserved aa motives of the RdRp. Therefore,
sequence data spanning this region is available for most NoV
strains. In the RdRp the feline NoV displayed high identity to
animal GIV.2 NoV strains and to other unusual canine NoV
strains that are highly divergent in the VP1 and likely constitute a
novel NoV genogroup (GVI) [7,9].
Although a number of GIV NoVs have been detected in
humans and sewage samples thus far [36,37], the full-length
genome sequence of GIV NoVs is not available for detailed
comparison with other NoV genogroups. In this study the
complete genome sequence of a GIV NoV was determined and
compared with full-length genomic sequences of NoV strains
available in the databases, revealing the highest nt identity to GII
NoVs (56.4–57.6% nt), whilst nt identity to GI, GIII and GV NoV
was #47.1% (Table 3, Figure 1). This confirms that NoV
genogroups GII and GIV are genetically much more related to
each other than to other NoV genogroups. The GIV includes both
animal (carnivores) GIV.2 and human GIV.1 viruses [6,7].
Human GIV.1 NoVs are identified only sporadically although
sewage-based surveillance studies conducted in some countries
suggest that these NoVs are rather common [37]. Human GIV.1
NoVs are more related to carnivore GIV.2 NoVs than to other
humans NoV genogroups (GI and GII), thus suggesting an
intersection during the evolution of GIV NoVs, likely due to the
social interactions of humans with carnivores during the process of
domestication and to the possibility of heterologous infections, as
demonstrated under experimental conditions [38,39].
In conclusion, the results of this study demonstrate that: i)
members of two distinct calicivirus genera (vesivirus and norovirus)
infect domestic cats; ii) NoVs detected in cats are similar to NoVs
found in other carnivores (lions and dogs), thus suggesting inter-
species circulation for GIV.2 NoV in these animal species. Larger
epidemiological investigations and animal experiments are war-
ranted to assess firmly the role of NoV infections in cats. Also,
these findings pose a challenge for epidemiological studies of feline
enteric pathogens, highlighting the need for reliable NoV-specific
diagnostic assays.
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